A randomized, double-blind, parallel group, phase II study estimated the overall survival for two separate doses (250mg
Posted: Tue Jul 05, 2022 9:18 am
A randomized, double-blind, parallel group, phase II studyestimated the overall survival for two separate doses (250mg and500mg) of an anticancer agent developed for the treatment of lungcancer. The overall survival curves are attached.
Questions:
1. Which group had the best survival?
2. What was the median survival in each group?
Overall survval (normal N 8 8 Proportion event free 2 2 8 wo
Questions:
1. Which group had the best survival?
2. What was the median survival in each group?
- A Randomized Double Blind Parallel Group Phase Ii Study Estimated The Overall Survival For Two Separate Doses 250mg 1 (19.57 KiB) Viewed 12 times